Egetis Therapeutics AB Stock Chart

Egetis Therapeutics AB (LSE) · Health Technology. stock live price and technical analysis view. Follow LSE data on Alerta Chart.

Checking data access...

About Egetis Therapeutics AB

LSE
Market Cap
$1.87B
Shares Out.
359.24M
Sector
Health Technology
Industry
Pharmaceuticals: Major

Egetis Therapeutics AB is an innovative and integrated pharmaceutical company, which engages in the development of new drugs for treatment of serious diseases. Its projects include Emcitate for the treatment of patients with monocarboxylate transporter 8 (MCT8) deficiency. The company was founded by Torsten Almén, Heidi Brurok, Louis J. Ignarro, Per Jynge, Jan Olof Gustav Karlsson, Ingemar Lundström, and Rob Towart in 2006 and is headquartered in Stockholm, Sweden.

www.egetis.com

Related Markets

Market Hub:Stocks Hub

Need more analysis tools?

With Alerta Chart Pro Terminal, you can follow 4 charts at the same time, see depth (order book) data and set 25 active alerts.

Start for Free
0ABW.GB (0ABW.GB) Stock Live Chart & Technical Analysis | Alerta Chart | Alerta Chart